Literature DB >> 21957296

A domain in the herpes simplex virus 1 triplex protein VP23 is essential for closure of capsid shells into icosahedral structures.

Hong Seok Kim1, Eugene Huang, Jigisha Desai, Marieta Sole, Erin N Pryce, Mercy E Okoye, Stanley Person, Prashant J Desai.   

Abstract

VP23 is a key component of the triplex structure. The triplex, which is unique to herpesviruses, is a complex of three proteins, two molecules of VP23 which interact with a single molecule of VP19C. This structure is important for shell accretion and stability of the protein coat. Previous studies utilized a random transposition mutagenesis approach to identify functional domains of the triplex proteins. In this study, we expand on those findings to determine the key amino acids of VP23 that are required for triplex formation. Using alanine-scanning mutagenesis, we have made mutations in 79 of 318 residues of the VP23 polypeptide. These mutations were screened for function both in the yeast two-hybrid assay for interaction with VP19C and in a genetic complementation assay for the ability to support the replication of a VP23 null mutant virus. These assays identified a number of amino acids that, when altered, abolish VP23 function. Abrogation of virus assembly by a single-amino-acid change bodes well for future development of small-molecule inhibitors of this process. In addition, a number of mutations which localized to a C-terminal region of VP23 (amino acids 205 to 241) were still able to interact with VP19C but were lethal for virus replication when introduced into the herpes simplex virus 1 (HSV-1) KOS genome. The phenotype of many of these mutant viruses was the accumulation of large open capsid shells. This is the first demonstration of capsid shell accumulation in the presence of a lethal VP23 mutation. These data thus identify a new domain of VP23 that is required for or regulates capsid shell closure during virus assembly.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21957296      PMCID: PMC3209348          DOI: 10.1128/JVI.05791-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Roles of triplex and scaffolding proteins in herpes simplex virus type 1 capsid formation suggested by structures of recombinant particles.

Authors:  A Saad; Z H Zhou; J Jakana; W Chiu; F J Rixon
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

2.  Capsid assembly and DNA packaging in herpes simplex virus.

Authors: 
Journal:  Rev Med Virol       Date:  1997-07       Impact factor: 6.989

3.  Seeing the herpesvirus capsid at 8.5 A.

Authors:  Z H Zhou; M Dougherty; J Jakana; J He; F J Rixon; W Chiu
Journal:  Science       Date:  2000-05-05       Impact factor: 47.728

4.  Functional analysis of the triplex proteins (VP19C and VP23) of herpes simplex virus type 1.

Authors:  Mercy E Okoye; Gerry L Sexton; Eugene Huang; J Michael McCaffery; Prashant Desai
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

5.  Proteins specified by herpes simplex virus. 8. Characterization and composition of multiple capsid forms of subtypes 1 and 2.

Authors:  W Gibson; B Roizman
Journal:  J Virol       Date:  1972-11       Impact factor: 5.103

6.  Regulation of the yeast HO gene.

Authors:  L Breeden; K Nasmyth
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1985

7.  A novel genetic system to detect protein-protein interactions.

Authors:  S Fields; O Song
Journal:  Nature       Date:  1989-07-20       Impact factor: 49.962

8.  Multiple interactions control the intracellular localization of the herpes simplex virus type 1 capsid proteins.

Authors:  F J Rixon; C Addison; A McGregor; S J Macnab; P Nicholson; V G Preston; J D Tatman
Journal:  J Gen Virol       Date:  1996-09       Impact factor: 3.891

9.  Localization of the herpes simplex virus type 1 major capsid protein VP5 to the cell nucleus requires the abundant scaffolding protein VP22a.

Authors:  P Nicholson; C Addison; A M Cross; J Kennard; V G Preston; F J Rixon
Journal:  J Gen Virol       Date:  1994-05       Impact factor: 3.891

10.  Small capsid protein pORF65 is essential for assembly of Kaposi's sarcoma-associated herpesvirus capsids.

Authors:  Edward M Perkins; Daniel Anacker; Aaron Davis; Vishwam Sankar; Richard F Ambinder; Prashant Desai
Journal:  J Virol       Date:  2008-05-07       Impact factor: 5.103

View more
  6 in total

1.  The assembly domain of the small capsid protein of Kaposi's sarcoma-associated herpesvirus.

Authors:  Dale Kreitler; Christopher M Capuano; Brandon W Henson; Erin N Pryce; Daniel Anacker; J Michael McCaffery; Prashant J Desai
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

2.  Nelfinavir inhibits maturation and export of herpes simplex virus 1.

Authors:  Nene N Kalu; Prashant J Desai; Courtney M Shirley; Wade Gibson; Phillip A Dennis; Richard F Ambinder
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

3.  Inhibition of DNA-Sensing Pathway by Marek's Disease Virus VP23 Protein through Suppression of Interferon Regulatory Factor 7 Activation.

Authors:  Li Gao; Kai Li; Yu Zhang; Yongzhen Liu; Changjun Liu; Yanping Zhang; Yulong Gao; Xiaole Qi; Hongyu Cui; Yongqiang Wang; Xiaomei Wang
Journal:  J Virol       Date:  2019-02-05       Impact factor: 6.549

4.  Silencing herpes simplex virus type 1 capsid protein encoding genes by siRNA: a promising antiviral therapeutic approach.

Authors:  Fujun Jin; Shen Li; Kai Zheng; Cuiqin Zhuo; Kaiqi Ma; Maoyun Chen; Qiaoli Wang; Peizhuo Zhang; Jianglin Fan; Zhe Ren; Yifei Wang
Journal:  PLoS One       Date:  2014-05-02       Impact factor: 3.240

Review 5.  The A, B, Cs of herpesvirus capsids.

Authors:  Ritesh Tandon; Edward S Mocarski; James F Conway
Journal:  Viruses       Date:  2015-02-26       Impact factor: 5.048

6.  Epstein-Barr virus genome packaging factors accumulate in BMRF1-cores within viral replication compartments.

Authors:  Atsuko Sugimoto; Yoriko Yamashita; Teru Kanda; Takayuki Murata; Tatsuya Tsurumi
Journal:  PLoS One       Date:  2019-09-13       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.